Delivery Order SPE2DB22D3011-SPE2DB25FQ2HE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 27 mg tablets (100 count) valued at $4,175.73 on August 11, 2025, with completion targeted for August 12, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The products will be performed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) with a ceiling value of $1,386.06. This firm fixed-price delivery order, which is expected to be completed by July 30, 2025, represents a competitive procurement with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $1,471.36 delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 18 mg tablets (100-count) on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count) under a firm fixed-price contract valued at $1,362.35. This non-set-aside competitive award, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a routine pharmaceutical procurement through the federal medical supply chain. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) with a ceiling value of $1,334.40. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and represents a non-competitive set-aside award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, serving the company's federal medical procurement...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,186.76 for Methylphenidate ER 36 mg tablets (100-count) on August 1, 2025, with completion scheduled for August 4, 2025. This competitively awarded, firm fixed-price delivery order was placed without set-aside designations and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The pharmaceutical product supports federal medical supply requirements, primarily serving military...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,438.08 for methylphenidate ER 36 mg tablets (100-count supply) on July 22, 2025, with ultimate completion by July 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a $1,479.44 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Methylphenidate ER 36 mg tablets in a quantity of 100 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for Methylphenidate ER 54 mg tablets in quantities of 100, with a firm fixed price ceiling value of $2,311.33 and an ultimate completion date of August 4, 2025. This competitive award, which involved no set-aside designation, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count units) with a ceiling value of $1,307.87. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ2HEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 54 mg tablets (100-count) with a ceiling value of $1,896.30. This competitively awarded, non-set-aside order was issued on August 19, 2025, with an ultimate completion date of August 20, 2025, under firm fixed-price terms. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle that supports global pharmaceutical supply for military healthcare systems through December 2026. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, supplying an extensive range of pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities to defense and veteran healthcare systems. The firm fixed-price delivery order model allows DLA to procure specific pharmaceutical items on an as-needed basis while maintaining the flexibility of the broader IDC framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/19/25 |